Recent progress in an emerging area of designing aptamer and nanomaterial conjugates as molecular diagnostic and drug delivery agents in biomedical applications is summarized. Aptamers specific for a wide range of targets are first introduced and compared to antibodies. Methods of integrating these aptamers with a variety of nanomaterials, such as gold nanoparticles, quantum dots, carbon nanotubes, and superparamagnetic iron oxide nanoparticles, each with unique optical, magnetic, and electrochemical properties, are reviewed. Applications of these systems as fluorescent, colorimetric, magnetic resonance imaging, and electrochemical sensors in medical diagnostics are given, along with new applications as smart drug delivery agents.
(NPs), quantum dots (QDs), carbon nanotubes (CNTs), and magnetic nanoparticles has unique physical and chemical properties that can be used for various applications. Of particular relevance to this review are optical, magnetic, electrochemical, thermal, catalytic, and mechanical signals generated by these nanomaterials, making them ideal candidates for signal transductions in medical diagnostics.
In order for nanomaterials to be used as clinical probes, it is necessary to provide them with target recognition capability; this task is generally accomplished by functionalizing the nanomaterials with biomolecules. Proteins such as antibodies are well known targeting molecules to be conjugated onto the nanomaterials. Recently functional nucleic acids are an emerging class of molecules to be used together with nanomaterials for biomedical applications [3] [4] [5] [6] .
Functional nucleic acids are DNA or RNA molecules that can interact with or bind to a specific analyte, resulting in a conformation change or a catalytic reaction [7, 8] . Since DNA is more stable and cheaper to produce than RNA, this review is mainly focused on functional DNA conjugated nanomaterials. Functional DNA molecules include DNAzymes, aptamers, and aptazymes. DNAzymes (also called catalytic DNA or deoxyribozymes elsewhere) are DNA molecules that can catalyze many chemical and biological reactions in the presence of specific molecules, mostly metal ions as cofactors. Aptamers, on the other hand, are nucleic acid molecules that can specifically bind to chemical or biological molecules. Aptazymes are the combination of DNAzyme and aptamer molecules. Once functional DNAs are combined with nanostructured materials, they can endow the nanomaterials with their target recognition capability allowing the hybrid system to be used as a sensor or agent for imaging/targeted drug delivery.
The target recognition ability of functional DNA has already been used extensively with nanomaterials to develop biosensors [9] [10] [11] for various target molecules to detect DNA [12] [13] [14] , RNA [15] , and metal ions [3, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Among them, aptamers modified with nanomaterials have great potential to be used for clinical diagnostics as they can detect diverse targets ranging from small molecules and proteins to intact viruses and cells.
In this review, various nanomaterial-aptamer systems for potential application in clinical diagnostics will be covered. First, aptamers will be introduced and their advantages and disadvantages will be discussed in comparison with antibodies. Following that, methods of combining aptamers with different nanomaterials to produce diagnostic agents, such as fluorescence, colorimetric, surface enhanced Raman scattering (SERS), magnetic resonance imaging (MRI), and electrochemical detection, will be summarized. Finally, recent progress in using the aptamer-nanomaterial conjugates for targeted drug delivery will be discussed.
Overview of aptamers

Aptamer
Aptamers can be considered as nucleic acid analogue of antibodies; they can bind with high affinity and specificity to a broad range of targets, such as small molecules, proteins, viruses, or cells. The concept of nucleic acid binding to target molecules or proteins was first introduced when a RNA with high affinity and selectivity to viral or cellular proteins was observed during the investigation on HIV and adenovirus in 1980's [31] . Aptamers can possess strong affinities to target molecules, with dissociation constants down to nanomolar or picomolar range. Currently, nucleic acid aptamers have been selected for more than 150 targets [32] , including small molecules such as cocaine [33] and aspartame [34] , growth factors [35] [36] [37] [38] , peptides [39, 40] , toxins [41, 42] , viral proteins [43, 44] , and cells and bacteria [45] [46] [47] . Among them some aptamers received approval from the US Food and Drug administration (FDA) for vascular endothelial growth factor (VEGF)-165 isoform [48] and ocular vascular disease [49] . Recently, targeted drug delivery using polymeric nanoparticle (NP) and aptamer conjugates on prostate cancer cells has been demonstrated in vivo [50] , showing that aptamers have great potential in therapeutics and diagnostics [31, 48, 49, [51] [52] [53] [54] [55] [56] [57] .
In vitro selection of aptamer
Aptamers can be obtained via isolation from synthetic combinatorial libraries of nucleic acids through an in vitro selection process called SELEX (systematic evolution of ligands by exponential enrichment) [51, 58, 59] . The selection process starts with generating random sequences of 10 14 -10 15 oligonucleotide strands which are chemically synthesized and amplified with polymerase chain reaction (PCR) (Fig. 1) . The nucleic acid library is incubated with a target molecule, often immobilized onto a solid state matrix such as a gel or a column, so that the DNA or RNA having affinity to the target molecule can be captured. The target-bound nucleic acid molecules are separated from the unbound strands in the pool, following which the bound DNA or RNA strands are eluted from the target molecule and amplified via PCR to seed a new pool of nucleic acids enriched with sequences that have a higher affinity to the target. The next round of selection process is usually performed under more stringent conditions (such as lower target concentration and shorter time for binding). After ∼ 10-20 rounds of the selection processes, the oligonucleotide with the highest affinity to the target molecule can be obtained. Furthermore, cell-based SELEX has been recently reported which enables to isolate aptamers directly from living cells [32, 60] . This method allows selection of aptamers specific for the molecules present on the targeted cell. Since this work can be performed without the prior knowledge of the molecules on the cells, it not only allows early diagnostics but also opens opportunities for identification of new cancer cell markers.
Advantages of aptamers
Antibodies are being used in the majority of biomedical applications. Aptamers are an emerging class of molecules with several important advantages [51] [52] [53] [54] [55] . First, aptamers are efficient at binding not only to large molecules, such as proteins [61] and cells [62] , but also to small molecules, such as nucleotides [63, 64] , organic dyes [65] , amino acids [66] , and metal ions [67, 68] , while antibodies are generally competent in binding to mostly larger molecules. Therefore there is a potential niche market for aptamers in diagnostics and drug delivery when small molecules are the targets. Second, aptamers are selected in vitro, and therefore can be used to select for a wide range of targets, including toxic or non-immunogenic molecules. Furthermore, the selection process can be performed under non-physiological condition including extremely high or low temperatures or pHs. These properties are difficult to be obtained with antibodies since they are produced in vivo. Third, once an aptamer is selected, it can be obtained in a large amount through chemical synthesis which is cost-effective and has minimal batch to batch difference in activity. It is easy to chemically modify aptamers with a variety of fluorophores, electrochemical or Raman reporters, or functional group such as primary amine, thiol groups on either 5' or 3' end, on the bases, or on the backbone of DNA [69] . Moreover, aptamers can be incorporated into one, two or three dimensional DNA-based nanostructures [70] [71] [72] [73] [74] [75] which also have strong potential to be used for clinical and diagnostic applications [76] [77] [78] . In designing microarrays, aptamers can provide additional advantages. For example, as the size of aptamers is much smaller (∼1-2 nm, b10 kDa) than those of antibodies (∼10 nm and ∼155 kDa), aptamers have higher surface density [57] and less steric hindrance [51] , which helps to increase the binding yield. In addition, non-specific adsorption happens much less for nucleic acidimmobilized surfaces compared to protein immobilized surfaces [79] , which facilitates the engineering process. Finally, aptamers are much more stable to heat [80] , pH [50] , and organic solvents [81] than antibodies and, unlike antibodies, can be denatured and renatured multiples times without significant loss of activity [82] . These properties make aptamers an excellent choice for biomedical applications.
Challenges facing aptamer-based diagnostics
Although aptamers are excellent candidates as diagnostic and drug delivery agents, there are still a few issues that have yet to be addressed for their practical applications. One issue is that nucleic acid aptamers could be vulnerable to nuclease degradation in cells or in blood [56] . This problem can be more significant for RNA aptamers because RNA molecules are much less stable to hydrolysis in biological fluid. To overcome this problem, several strategies have been proposed to increase the stability of aptamers, such as modification of aptamers with 2'-aminopyrimidine [83] , 2'-fluoropyrimidine [83] , or 2'-O-methyl nucleotides [84] . Another limitation aptamers might have is the necessity to limit its administration to local regions, since there is a possibility that proteins in untargeted organs can also be affected. However, some preliminary results showed the possibility of systematic delivery [51, 52] . Finally, one of the major challenges is the development of general methods to convert the highly specific molecular recognition between aptamers and their targets into detectable signals. Conjugation of aptamers with nanomaterials can be an ideal way to overcome this hurdle.
Conjugation of nanomaterials and aptamers for biosensing and diagnostics
Fluorescence based sensors
Aptamers can be easily modified with a variety of organic dyes and thus fluorophore-based detection method has been the most widely demonstrated [3, 5, 6, 85] . Since this review mainly focuses on the nanomaterial-based detection, fluorophore-based detection will not be discussed here.
Quantum dots (QDs) or semiconductor NPs are one type of fluorescent nanomaterials with several unique optical properties [86] [87] [88] . As compared to organic fluorescent dyes, quantum dots are more photostable and the wavelength of the emitted light can be controlled by changing their size and composition of the materials. Furthermore, QDs have very broad excitation range but sharp emission, making it possible to excite different QDs with a single wavelength and yet result in variety of emission wavelengths. Based on these attractive properties, QDs have been broadly used for bioimaging and diagnostics.
QDs functionalized with DNA [89] [90] [91] have been used for the detection of DNA [92] and real time monitoring of hybridization procedure [93] . The first QD conjugated with aptamer was reported by Ellington and co-workers for energy transfer based detection of thrombin (see Fig. 2A ) [94] . In this work, thrombin aptamers functionalized on QDs were hybridized with a complementary DNA strand labeled with a quencher at the end. In the absence of thrombin, the fluorescent signal of QDs was quenched because the QDs were placed in close proximity to the quenchers, resulting in the energy transfer from the quantum dot to the quencher. The presence of thrombin, however, recovered the signal as the thrombin-aptamer interaction induced the release of the complementary strand containing quencher.
A different type of QD-aptamer sensor was developed by Strano and co-workers (see Fig. 2B ) [95] . In this work, they conjugated QDs with thrombin-specific aptamers. When thrombin was added, the interaction of thrombin with aptamers brought them close to QDs. Selective quenching of fluorescence occurred due to the charge transfer occurring from thrombin to the QDs. The sensor was very sensitive, with a detection limit of 1 nM, and had high selectivity.
For medical applications, it is advantageous to perform multiplexed detection of more than one analyte using a single sensor in an "one-pot" process. Our group reported multiplexed detection of adenosine and cocaine using both QDs and gold nanoparticles (AuNPs) conjugated with aptamers ( Fig. 3) [96] . In this work, aggregates of QDs with emission peak at 525 nm and AuNPs were formed by DNA aptamer specific for adenosine. In parallel, aggregates of QDs with emission peak at 585 nm and AuNPs were formed by a cocaine specific DNA aptamer. While fluorescence from the sensor composed of the mixture of both assemblies was initially quenched due to energy transfer from each QD to AuNPs, the signal was enhanced at 525 nm with the addition of adenosine, or at 585 nm in the presence of cocaine as analyte-aptamer interaction induced disassembly of QD-AuNP aggregates. Fluorescence increase at both 525 nm and 585 nm was observed when both analytes were present. It was recently reported that carbon nanotubes (CNT) also have fluorescence in the near-IR range which is advantageous for cell imaging by avoiding the high background fluorescence from the organelles in the cells [97] . Therefore, aptamer conjugated CNTs also have potential to be used as a fluorescence tag for cancer cell imaging. First, a photodynamic therapy agent generating singlet oxygen ( 1 O 2 ) in the presence of α-thrombin was demonstrated using a photosensitizer labeled α-thrombin aptamer and single wall nanotube (SWNT) complex [98] . As the aptamer wrapped around the SWNT in the absence of target molecule, the labeled photosensitizer was placed close to SWNT, quenching the generation of singlet oxygen. On the other hand, the interaction between thrombin and aptamer induced release of photosensitizer from SWNT, generating singlet oxygen in the presence of light source. The same group further extended the methodology for detection of biomolecular interactions based on fluorescence [99] .
Furthermore, fluorophore labeled DNA can also be immobilized on a solid surface. This provides several advantages such as low fluorescence background, regeneration, and long term storage compared to solution based fluorescence sensors [25] . In addition, the performance of fluorescence sensors can be engineered by the property of the material on which aptamer is immobilized. As the sensitivity and volume of the sample can be critical for some biomedical diagnostic applications, we investigated the influence of materials using Pb 2+ specific DNAzyme labeled with fluorescein and Au surface as a model system. By immobilizing DNAzyme on a planar Au substrate, we could reach an order of magnitude improvement (1 nM) in the detection limit due to lower background, compared to its corresponding solution based sensor (10 nM) [100] . Au coated nano capillary membrane (NCAM) further enhanced fluorescent signal twelve times due to the increased surface area provided by the nanopore walls of the membrane and increased surface roughness. This NCAM sensor also allowed regenerations by rehybridization of fresh DNA strand and storage up to 30 days without significant loss of activity [101] . Solid supported fluorescent sensors can also incorporate ratiometric fluorescence internal controls which allow to standardize the number of molecules immobilized on the surface and to perform real time detection of target molecules [102] . In addition, aptamers or DNAzymes can be incorporated into microfluidic devices which have advantages of generating low waste volume output, consuming less amount of detecting material, and having facile regeneration capabilities [103, 104] . The Pb 2+ DNAzyme integrated NCAM based microfluidic device consumed 4.2 picoliter of DNAzyme for each detection with detection limit of 11 nM [105] . Finally, by changing the design of the microfluidic device, multiple detections could be made in a single cycle with minimal detection variation [106] .
Colorimetric sensor
As fluorescence based sensors rely on the emission of the fluorophores or quantum dots after excitation at a certain wavelength, it is necessary to have analytical equipments such as fluorimeter or fluorescence microscope for detection. For real-time and on-site use, however, it is more convenient if detection can be carried out without any equipment. Colorimetric detection provides an advantage in this regard, since it allows detection to be made by naked eye [16, [107] [108] [109] [110] [111] . Novel metallic nanoparticles, such as gold or silver nanoparticles, are ideal materials that allow colorimetric detection [112] . AuNPs have very high extinction coefficient, making their colors distinguishable without any instrument at only a few nanomolar concentration. Dispersed AuNPs smaller than 100 nm in solution originally have reddish color. When AuNPs aggregate, their color changes from red to blue due to a shift of their surface plasmon resonance to a higher wavelength [113] .
There are two different methods for designing AuNP-DNA based colorimetric sensors. The labeled method is based on directed assembly (or disassembly) of AuNPs caused by analyte-specific binding, cleavage, or conformational change of the DNA molecules [8, 16, 113] . Two batches of AuNPs, each functionalized with a different DNA strand via Au-thiol chemistry, are mixed together, resulting in dispersed AuNPs due to the strong negative charge of DNA modified on AuNP surface. In the presence of a bridging DNA strand, which is complementary to the two different DNA strands functionalized on AuNP surface, AuNPs aggregate with their color changing from red to blue. The label-free method takes advantage of different adsorption properties of single stranded (ss) DNA and double stranded (ds) DNA onto citrate modified AuNPs [114] . Citrate modified AuNPs are naturally unstable in the presence of NaCl and can easily aggregate. Since ssDNA is flexible and can partially uncoil its strand, it can be readily adsorbed on AuNPs surface resulting in the enhancement of electrostatic repulsion between AuNPs, which in turn stabilizes AuNPs even in the presence of NaCl. On the other hand, as dsDNA is stiff and is covered with negatively charged phosphate backbone, it will repel the negatively charged citrate modified AuNPs, resulting in aggregation of AuNPs.
Both labeled and label-free methods have been used for colorimetric detection of DNA [12] [13] [14] , RNA [15] , and various metal ions [16] [17] [18] [19] 24, 26, 28, 29] when DNA or DNAzymes are incorporated into the systems. Recently, a systematic comparison of the two methods using the same DNAzyme has been reported, providing a practical guidance in how to choose between the two methods [115] .
Aptamers can also be incorporated into both systems for colorimetric detection. In 2006, we reported colorimetric sensors specific for adenosine and cocaine using the labeled method [111] . In the absence of target molecule, the aptamer-modified AuNPs remained aggregated, appearing blue; in the presence of the target, the AuNPs disassembled, resulting in red color (see Fig. 4A ). The color change occurred in less than 1 minute. The labeled method has been used for detection of other small molecules and proteins [108, 110] . Dong, Wang, and coworkers demonstrated that labeled aptamerAuNP colorimetric system could be used for detection of thrombin with extremely high sensitivity (with detection limit of 14 fM) using dot-blot arrays [116] . Furthermore, our group reported multiplex colorimetric sensing system based on smart AuNPs responsive to multiple stimuli with controlled cooperativity [117] .
Fan and co-workers reported colorimetric detection of ATP using unmodified AuNPs and ATP aptamers based on label-free method (see Fig. 4B ) [118] . The AuNPs aggregated displaying a blue color in the absence of ATP but remained dispersed displaying a red color in its presence. The sensor had high selectivity and a detection limit of 0.6 µM. This label-free aptamer based colorimetric detection method was also used for other analytes such as potassium [19] , cocaine [118] , thrombin [119] .
Li and coworkers reported a detection method based on a combination of labeled and label-free methods (see Fig. 4C ). They first chemically functionalized short DNA strands on AuNPs and hybridized those strands with long partially complementary aptamer strands. The long aptamer DNA provides additional negative charge to AuNPs, enhancing their stability at a certain concentration of NaCl. Introduction of target molecules caused interaction between the target molecule and the aptamer strand, resulting in the release of the aptamer strand from AuNP. The targeted release of aptamers decreased the number of negatively charged DNA strands on AuNPs, lowering the stability of AuNPs. This turn-on colorimetric sensor, The interaction between unmodified AuNPs and unlabeled ssDNA strand has been used to make labelfree sensors. In the presence of adenosine, dsDNA containing an adenosine aptamer strand (brown) releases ssDNA (green) which can be adsorbed onto unmodified AuNPs. AuNPs remain dispersed with red color even in the presence of NaCl due to enhanced stability of AuNPs provided by ssDNA. In the absence of adenosine, dsDNA with adenosine aptamer strand stays hybridized. The electrostatic repulsion between dsDNA and AuNP as well as the stiffness of dsDNA make them ineffective in preventing NaCl induced charge screening on AuNP surface, causing aggregation of AuNPs with color change from red to blue. (C) Both labeled and label-free method has been combined to make an adenosine sensor. AuNPs are chemically functionalized with DNA (blue) and hybridized with adenosine aptamer strand (brown). In the presence of adenosine, aptamer strands are released from AuNPs, decreasing the stability of AuNPs. The resulting aggregation of AuNPs causes their color change from red to blue. changing its color from red to blue in the presence of analytes, had high selectivity and a detection limit of 10 μM [120, 121] .
While AuNP based colorimetric sensors provide a way to carry out detection without the need for analytical equipment, it still requires careful handling of micro-liter scale solutions, which is not trivial for most users, especially those at home. Therefore it is preferred to develop more user-friendly diagnostic kits, such as dip-stick test. Since the discovery of antibodies, there have been a number of reports converting antibody based detection onto the lateral flow devices [122] and many of the kits, such as home pregnancy test, are commercially available. In contrast, few reports demonstrating nucleic acid based lateral flow devices have appeared in the literature. For example, Ioannou and Christopoulos et al. used DNA functionalized AuNPs to analyze the hybridization of DNA on lateral flow devices [123] . We developed a lateral flow device based on labeled AuNP and aptamer system (see Fig. 5 ) [124] . The lateral-flow device is composed of four components, a wicking pad, a glass fiber conjugation pad, a membrane, and an absorption pad. Biotin labeled AuNP aggregates containing cocaine aptamers were dropped onto the conjugation pad, and streptavidin was immobilized on a specific part of the membrane to capture biotinylated AuNPs. When the wicking pad of lateral flow device was dipped into a sample solution containing cocaine, the solution flowed along the conjugation pad, rehydrated and induced disassembly of AuNP aggregates. Since biotin was labeled on disassembled AuNPs, the AuNPs could be captured on the part of the membrane with streptavidin forming a red line. When the concentration of cocaine in the solution increased, the intensity of the red line formed on the membrane became higher and the estimated detection limit was ∼ 10 μM. In addition to the simplicity in testing without the need of precise solution transfer, the method was also more sensitive than many solution-based tests, due to the integration of binding, separation, and detection on a simple test paper-like platform. Red lines did not appear with control analytes, showing good selectivity of the lateral flow device. In the process, we discovered a new design of the lateral flow device taking advantage of the physical size difference of nanoparticles in various assembly states, which provides a critical control for assessing the performance of the device. The lateral flow device could also be applied to adenosine by using the aptamer specific for the molecule. Since aptamers for a broad range of molecules have been obtained, this method is general enough to be adapted to develop "dip-stick" tests for any analyte for which an aptamer can be obtained. In addition, the lateral flow device also performed well in human blood serum, showing its compatibility with biological samples. Recently, Pelton, Li and coworkers reported that aptamers can be immobilized on cellulose surface as a potential platform for detection of medically relevant biomolecules [125] , making it possible for medical diagnostics.
Surface Enhanced Raman Scattering (SERS)
Raman scattering is an optical methodology utilizing the inelastic scattering of a photon. It has several advantages over fluorescence as it can provide structural information of a molecule, does not suffer from photobleaching, and has a much narrower spectral width (b1 nm, half widths), which is advantageous for multiplexed detection. As Raman cross section is inherently weak and inefficient (10 -30 cm 2 per molecule vs 10 -16 cm 2 per molecule for fluorescence), there has been limitation in utilizing Raman scattering as a tool for highly sensitive detection [126] . In 1974, however, it was reported that Raman scattering can be significantly amplified when molecules are absorbed on metal surface, due to the extremely high electromagnetic fields produced on hot spots generated on the surface of metals [127] [131] . The detection of proteins or small molecules using SERS has also been reported using DNA aptamers. Wang, Dong, and co-workers used aptamers to detect α-thrombin by SERS (See Fig. 6A ) [132] . Thrombin has two binding sites specific for two different DNA aptamers with high affinity [61, 133] . A substrate functionalized with aptamer 1 was first treated with thrombin and then incubated in AuNPs functionalized with aptamer 2 and SERS reporter. As a result, AuNPs were attached to the surface through aptamer-thrombin interaction. After Ag NP deposition, the NPs became larger, resulting in highly enhanced Raman scattering and thus highly sensitive signal. The detection limit was reported as 0.5 nM and the system had high selectivity over both β-and γ-thrombins. Jiang, Yu, and co-workers demonstrated a different methodology to detect adenosine using aptamers [134] . They used a dsDNA composed of both an adenosine aptamer strand and a partially complementary short DNA strand with a Raman reporter (Fig. 6B) . In the presence of adenosine, the aptamer strand underwent structure switching, resulting in denaturation of dsDNA. Therefore the Raman probe labeled oligonucleotide was released in solution. The released strand later hybridized to the complementary DNA which was previously immobilized on a rough gold surface. This chain of processes resulted in an enhanced Raman signal.
SERS can not only be used in vitro, but also be used in vivo for tumor targeting. Nie and co-workers recently reported that polyethylene glycol (PEG) modified 80 nm AuNPs which incorporated both Raman reporter and antibody modification could be used as SERS nanoparticles for targeted imaging of tumors [135] . Gambhir and coworkers also demonstrated non-invasive whole body Raman imaging and in vivo tumor imaging using SERS nanoparticles and single wall CNTs [136] .
Magnetic Resonance Imaging (MRI)
While fluorescence and SERS have been used in imaging in vivo, the penetrating length is limited. MRI, on the other hand, does not have this limitation and allows 3D imaging of the whole human body with clinically available instruments all over the world. Currently, MRI is mostly effective only when the difference in tissues, such as between a solid tumor and a regular tissue, is large, with little molecular information. For future MRI imaging, it is preferred to use MRI to detect molecular markers of the tumor before the tumor develops. To achieve this goal, new smart MRI contrast agents responsive to small molecular markers are required.
Superparamagnetic iron oxide nanoparticles are a new class of MRI contrast agents, catching the attention of many researchers due to their advantageous properties over gadolinium-based contrast agents.
It has been shown in literature that superparamagnetic iron oxide nanoparticles can be coupled to biological molecules including thiol modified oligonucleotides for active targeting. Weissleder and coworkers demonstrated that cross-linked dextran iron oxide (CLIO) nanoparticles can be functionalized with DNA and this material can be used to detect sequence specific oligonucleotide by MRI [137, 138] . CLIO nanoparticles change the spin-spin relaxation time (T2) of surrounding water protons. In addition, researchers observed that these nanoparticles become more efficient in decreasing T2 when assembled into bigger clusters. This observation has been confirmed by many different assembly and disassembly systems [137, [139] [140] [141] . Based on this principle it is possible to distinguish assembled and dissembled states of the nanoparticles and therefore detect the analytes which results in such transition.
Recently we have developed a method for detecting chemical and biological molecules using aptamer functionalized CLIO nanoparticles. Adenosine aptamer could induce disassembly of CLIO nanoparticle aggregates in the presence of adenosine which was observed by MRI with an increase in the brightness of T2-weighted MR images (Fig. 7A ) [142] . The control analytes without any activity on adenosine aptamer did not show any change in MR images. The CLIO nanoparticles functionalized with mutated aptamer (which does not interact with adenosine) did not show any change in MR image, either. In order to demonstrate the response on proteins instead of small molecules and observe the change in contrast, we have tested the system for thrombin [143] . The CLIO nanoparticles functionalized with thrombin aptamers assembled in the presence of thrombin, which could be observed by the decrease of brightness in T2 weighted MR images (Fig. 7B) . Such an aptamer functionalized superparamagnetic iron oxide nanoparticles are suitable for non-invasive in vivo imaging of small molecular markers, making early diagnostics and treatment of diseases possible before the progression of the disease to late stages.
Electrochemical detection
Most of the optical detection methods require highly transparent sample solution as the color of the solution might interfere with the optical signal generated from sensors. For biomedical diagnostics on biological samples, such as blood, it is necessary to find an alternative method. Electrochemical detection provides another important route for non-transparent samples since the signal transduction can be accomplished by non-optical means [144] .
Electrochemical detection is carried out by measuring changes in redox states of redox active probes. As the labels can be easily attached to DNA, electrochemical method has been used extensively to detect DNA [145] [146] [147] . There are several different strategies reported for electrochemical detection of analytes using aptamers. One takes advantage of the redox state change induced by catalysts immobilized on DNA aptamers. Since thrombin has two binding sites for two different aptamer strands [61, 133] , it is possible to immobilize thrombin on Au electrode with one aptamer and bind a catalyst which is tethered on the other aptamer. An example of using platinum nanoparticle (Pt NP) as a catalyst label is shown in Fig. 8A [148] . The thrombin aptamer 1 was first immobilized on Au electrode and allowed to bind to thrombin. The Pt NP tethered with thrombin aptamer 2 was then introduced to form thrombin-aptamer-Pt NP sandwich complex. The Pt NPs catalyzed H 2 O 2 reduction to H 2 O, resulting in cathodic currents which enabled thrombin detection with a detection limit as low as 1 nM. Similar methods using biocatalysts were also reported [149, 150] but Pt NPs showed higher sensitivity, probably due to the effectiveness of the Pt NP catalyst. It is also possible to carry out electrochemical sensing based on the conformation change of redox reporter labeled aptamers immobilized on Au electrode for detection of small molecules [151] [152] [153] and protein [154] [155] [156] [157] .
The electrochemical sensors mentioned above are highly sensitive. To extend the methodology to multiplex detection, Wang and coworkers used protein labeled QDs with different chemical compositions [158] . In this work, they immobilized two different aptamers on a Au surface which were specific for thrombin and lysozyme, and then introduced both thrombin and lysozyme labeled with CdS and PbS QDs, respectively (see Fig. 8B ). The protein analytes (either thrombin or lysozyme) were added afterwards, replacing corresponding QD labeled proteins on the surface with sample analytes. By monitoring the remaining QDs via electrochemical stripping detection, it was possible to identify the proteins in the sample solution. Using this method, subpicomolar detection limit was achieved with high selectivity.
Willner and co-workers demonstrated label-free detection of adenosine mono-phosphate (AMP) using ion-selective field effect transistors (ISFET) [159] . In this work, they immobilized adenosine selective aptamers on Al 2 O 3 gate surface and hybridized aptamers with short complementary DNA strands (see Fig. 9A ). The addition of AMP induced structure switching of aptamer strand, causing release of short partially complementary DNA strand. This released complementary strand altered the charge associated on the gate, changing the source to drain current. Gate-to-source potential (V gs ) of the device increased as the concentration of AMP became higher and the detection limit of the device was 50 µM. Carbon nanotube (CNT) is an interesting nanomaterial with either metallic or semiconductive properties based on its structure, such as chirality or diameter [160] [161] [162] . As CNTs have the size (c.a. 1-2 nm diameter) comparable to most biomolecules as well as interesting physical and chemical properties, there has been intense investigation to conjugate CNTs with biomolecules to form a hybrid system. It has been reported that DNA can either noncovalently bind to the external part of CNT walls after electrical, thermal, or sonication treatment [163] , or covalently bind to the carboxyl groups introduced on the CNT sidewalls after oxidization treatment [164] [165] [166] [167] . Bifunctional reagents can also be used to introduce functional groups on DNA [168, 169] .
CNTs can be used as a conducting channel in field effect transistors (FET). As the interaction between biomolecules and CNTs can modulate the conductivity of the FET, detection can be accomplished based on the change of electrical signal. Detection of DNA has been demonstrated using CNT based FETs.
Lee and co-workers were the first to report the detection of adenosine using aptamer conjugated single wall carbon nanotube (SWNT) field effect transistor (FET) [170] . In their work, they modified the surface of CNT with CDI-Tween via hydrophobic interaction [169] and covalently attached 3'-amine modified thrombin aptamer DNA on it (Fig. 9B) . As soon as thrombin was dropped on the surface of the device, the conductance of the device decreased abruptly and soon saturated, which might be attributed to the screening of negative charges of DNA aptamers or positive charge induced by the introduction of thrombin. The detection limit was as low as 10 nM and the device had selectivity over the protein elastase, which is another serine protease with molecular weight and isoelectric point similar to thrombin.
It is reported that aptamers work much more efficiently than antibodies in CNT FET sensors. Tamiya and co-workers compared the performance of IgE specific aptamer and monoclonal antibody for the detection of immunoglobulin E (IgE) on CNT FET system [171] . Even though they could observe IgE induced conductance decrease for both aptamers and antibodies systems, the aptamer system worked much more effectively than antibody with the detection limit of 250 pM. The reason is mainly due to the small size of aptamers (1-2 nm) compared to antibodies (∼10 nm) that allows target protein to bind to CNT within the electrical double layer in physiological conditions, making the detection possible. This method is versatile and its application for the detection of microorganism was also reported using Escherichia coli (E. coli) as an example [172] . By employing RNA based E. coli aptamers, the study demonstrated the detection of E. Coli in less than 20 minutes with selectivity over salmonella.
Targeted drug delivery in cells using aptamer-nanomaterial conjugates
In addition to molecular diagnostics and imaging discussed above, the aptamer-nanomaterial conjugates have also been applied in targeted drug delivery, making it possible for therapeutic applications. Farokhzad, Langer, and co-workers reported a smart QD-aptamer conjugate which serves both as a fluorescence imager and a drug delivery vehicle (See Fig. 10 ) [173] . The QD-aptamer conjugate was composed of 3 components; QD, prostate cancer (PCa) cell specific RNA aptamer, and doxorubicin (Dox) which is commonly used anthracycline drug with fluorescence when intercalated into CG pairs of double stranded oligonucleotide. Aptamers were conjugated to QDs and Dox was intercalated to the aptamer strand [174] , forming QDaptamer-Dox system. The QD-aptamer-Dox system was initially 'off' since the fluorescence of QD was transferred to Dox and the fluorescence of Dox was also quenched by the dsRNA aptamer, both via energy transfer between the two components. Once injected into cancer cell, the QD-aptamer-Dox system gradually released Dox, caused by the binding of target molecule onto RNA aptamer. This Dox release recovered the fluorescence of the QD. Therefore the QDaptamer-Dox system not only allows targeted drug delivery, but also enables monitoring drug release and imaging target cells. A similar methodology has also been applied to superparamagnetic iron oxide nanoparticles for prostate cancer imaging and therapy [175] .
Lippard, Farokhzad, Langer, and coworkers demonstrated aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles for targeted delivery of cisplatin to prostate cancer cells [176] . Prostate-specific membrane antigen (PSMA) targeting aptamer functionalized controlled release block-copolymer nanoparticles could target and be taken up by human prostate PSMA overexpressing LNCaP epithelial cells with high efficiency, but not to PC3 cancer cells. Furthermore, the aptamer-Pt(IV) encapsulated NPs were much more effective than the free cisplatin or nontargeted nanoparticles against the LNCaP cells for drug delivery. In addition, Langer and coworkers were the first to demonstrate aptamer based drug delivery in vivo [50] . They showed that docetaxel (Dtxl) containing di-block copolymer nanoparticles functionalized with RNA aptamers could significantly decrease tumor with reduced toxicity compared to Dtxl alone.
Tan and coworkers demonstrated an advantage of using multiple aptamer-conjugated nanorods as a multivalent probe for targeted cancer cell imaging [177] . Many targeting molecules, such as antibodies or aptamers, have moderate binding affinities which prevent efficient targeted cell imaging. By using Au-Ag nanorods conjugated to up to 80 fluorophore labeled aptamers, 300 fold increased fluorescence signal and 26 times higher binding affinity was obtained compared to individual aptamer strand. This methodology enables to target and image cells with low density binding sites or targeting molecules with relatively low binding affinities.
Targeted delivery of DNA or RNA molecules into cells is among one of potent therapeutic strategies for genetic diseases such as cancer. However, practical application of DNA or RNA delivery in cellular environment is difficult as those molecules can be generally degraded or digested by nucleases or enzymes. It is reported that SWNTs can be used as a protective cargo for delivery of ssDNA into cells [178] . The work from Tan and coworkers demonstrated the stability of delivered DNA against nuclease and enzymes in vitro. In addition, it has been shown that specific mRNA targeting DNA could be delivered efficiently into cells in DNA/SWNT-complexed form and the delivered DNA was active. This work demonstrated the possibility of using SWNTs as DNA/RNA delivery molecules for diagnostic and therapeutic applications. Furthermore, it has been reported recently that viral caspid carrier can also be functionalized to DNA aptamer and these can potentially be used for targeted drug delivery [179] . Capsids functionalized with 41 mer DNA aptamer specific for tyrosine kinase receptor could successfully target and be uptaken by Jurkat T cells.
We, in collaboration with Wong and Cheng groups, recently reported cell specific drug delivery based on aptamer functionalized liposomes [180] . Liposome is, by far, the most widespread system used for drug delivery. By conjugating aptamers specific to nucleolin, which is overexpressed on cancer cell plasma membrane, along with cisplatin encapsulated inside liposomes, we demonstrated targeted delivery of cisplatin onto nucleolin overexpressing breast cancer MCF-7 cells but not to control prostate cancer cells (LNCaP cell). Furthermore, the extent of drug release can be controlled by using a complementary DNA of the aptamer as an antidote so that the drug effects can be readily controlled.
Conclusion
By summarizing recent progress in developing methods of integrating aptamers with a diverse number of nanomaterials, we have shown that these novel bionanomaterials can be used as highly sensitive and selective diagnostic agents and targeted drug delivery agents. As each nanomaterial has different optical, electrochemical, magnetic, and mechanical properties, medical diagnostic and drug delivery agents with diverse characteristics can be used for different biomedical applications, making them an excellent alternative to antibody-based medical applications.
Most of the agents introduced here, however, used available aptamers specific for molecules such as adenosine, cocaine and thrombin, as a proof of concept only, and most of tests have been carried out in vitro. To realize the full potentials of such bionanomaterials systems, one needs to carry out more selections for aptamers that are specific for more clinically relevant targets such as cancer markers and viruses, and demonstrate the effectiveness of the systems in vivo. Given progresses made in the field in such a short period of time, applications of these aptamer-nanomaterial based sensors in clinical applications will be realized in the near future.
